Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Effect of Iron Supplementation on the Outcome of Non-Progressive Pulmonary Mycobacterium tuberculosis Infection.

Kolloli A, Singh P, Rodriguez GM, Subbian S.

J Clin Med. 2019 Aug 2;8(8). pii: E1155. doi: 10.3390/jcm8081155.

2.

Author Correction: The wide utility of rabbits as models of human diseases.

Esteves PJ, Abrantes J, Baldauf HM, BenMohamed L, Chen Y, Christensen N, González-Gallego J, Giacani L, Hu J, Kaplan G, Keppler OT, Knight KL, Kong XP, Lanning DK, Le Pendu J, de Matos AL, Liu J, Liu S, Lopes AM, Lu S, Lukehart S, Manabe YC, Neves F, McFadden G, Pan R, Peng X, de Sousa-Pereira P, Pinheiro A, Rahman M, Ruvoën-Clouet N, Subbian S, Tuñón MJ, van der Loo W, Vaine M, Via LE, Wang S, Mage R.

Exp Mol Med. 2019 Jul 4;51(7):71. doi: 10.1038/s12276-019-0252-0.

PMID:
31270317
3.

Attainment of target rifampicin concentrations in cerebrospinal fluid during treatment of tuberculous meningitis.

Mezochow A, Thakur KT, Zentner I, Subbian S, Kagan L, Vinnard C.

Int J Infect Dis. 2019 Jul;84:15-21. doi: 10.1016/j.ijid.2019.04.026. Epub 2019 Apr 30.

4.

Adipose Tissue Regulates Pulmonary Pathology during TB Infection.

Ayyappan JP, Ganapathi U, Lizardo K, Vinnard C, Subbian S, Perlin DS, Nagajyothi JF.

MBio. 2019 Apr 16;10(2). pii: e02771-18. doi: 10.1128/mBio.02771-18.

5.

Biphasic Dynamics of Macrophage Immunometabolism during Mycobacterium tuberculosis Infection.

Shi L, Jiang Q, Bushkin Y, Subbian S, Tyagi S.

MBio. 2019 Mar 26;10(2). pii: e02550-18. doi: 10.1128/mBio.02550-18. Review.

6.

The Synergistic Effects of the Glutathione Precursor, NAC and First-Line Antibiotics in the Granulomatous Response Against Mycobacterium tuberculosis.

Teskey G, Cao R, Islamoglu H, Medina A, Prasad C, Prasad R, Sathananthan A, Fraix M, Subbian S, Zhong L, Venketaraman V.

Front Immunol. 2018 Sep 12;9:2069. doi: 10.3389/fimmu.2018.02069. eCollection 2018.

7.

Storage lipid studies in tuberculosis reveal that foam cell biogenesis is disease-specific.

Guerrini V, Prideaux B, Blanc L, Bruiners N, Arrigucci R, Singh S, Ho-Liang HP, Salamon H, Chen PY, Lakehal K, Subbian S, O'Brien P, Via LE, Barry CE 3rd, Dartois V, Gennaro ML.

PLoS Pathog. 2018 Aug 30;14(8):e1007223. doi: 10.1371/journal.ppat.1007223. eCollection 2018 Aug.

8.

The wide utility of rabbits as models of human diseases.

Esteves PJ, Abrantes J, Baldauf HM, BenMohamed L, Chen Y, Christensen N, González-Gallego J, Giacani L, Hu J, Kaplan G, Keppler OT, Knight KL, Kong XP, Lanning DK, Le Pendu J, de Matos AL, Liu J, Liu S, Lopes AM, Lu S, Lukehart S, Manabe YC, Neves F, McFadden G, Pan R, Peng X, de Sousa-Pereira P, Pinheiro A, Rahman M, Ruvoën-Clouet N, Subbian S, Tuñón MJ, van der Loo W, Vaine M, Via LE, Wang S, Mage R.

Exp Mol Med. 2018 May 22;50(5):66. doi: 10.1038/s12276-018-0094-1. Review. Erratum in: Exp Mol Med. 2019 Jul 4;51(7):71.

9.

Harnessing the mTOR Pathway for Tuberculosis Treatment.

Singh P, Subbian S.

Front Microbiol. 2018 Jan 30;9:70. doi: 10.3389/fmicb.2018.00070. eCollection 2018. Review.

10.

Role of the inositol pyrophosphate multikinase Kcs1 in Cryptococcus inositol metabolism.

Liao G, Wang Y, Liu TB, Kohli G, Qian W, Shor E, Subbian S, Xue C.

Fungal Genet Biol. 2018 Apr;113:42-51. doi: 10.1016/j.fgb.2018.01.006. Epub 2018 Feb 3.

11.

Effect of Mycobacterium tuberculosis infection on adipocyte physiology.

Ayyappan JP, Vinnard C, Subbian S, Nagajyothi JF.

Microbes Infect. 2018 Feb;20(2):81-88. doi: 10.1016/j.micinf.2017.10.008. Epub 2017 Nov 8.

12.

Host-Directed Therapeutic Strategies for Tuberculosis.

Kolloli A, Subbian S.

Front Med (Lausanne). 2017 Oct 18;4:171. doi: 10.3389/fmed.2017.00171. eCollection 2017. Review.

13.

The Capacity of Mycobacterium tuberculosis To Survive Iron Starvation Might Enable It To Persist in Iron-Deprived Microenvironments of Human Granulomas.

Kurthkoti K, Amin H, Marakalala MJ, Ghanny S, Subbian S, Sakatos A, Livny J, Fortune SM, Berney M, Rodriguez GM.

MBio. 2017 Aug 15;8(4). pii: e01092-17. doi: 10.1128/mBio.01092-17.

14.

Experimental Evolution of Mycobacterium tuberculosis in Human Macrophages Results in Low-Frequency Mutations Not Associated with Selective Advantage.

Guerrini V, Subbian S, Santucci P, Canaan S, Gennaro ML, Pozzi G.

PLoS One. 2016 Dec 13;11(12):e0167989. doi: 10.1371/journal.pone.0167989. eCollection 2016.

15.

IFN-ε protects primary macrophages against HIV infection.

Tasker C, Subbian S, Gao P, Couret J, Levine C, Ghanny S, Soteropoulos P, Zhao X, Landau N, Lu W, Chang TL.

JCI Insight. 2016 Dec 8;1(20):e88255. doi: 10.1172/jci.insight.88255.

16.

Development of immune-biomarkers of pulmonary tuberculosis in a rabbit model.

Dehnad A, Ravindran R, Subbian S, Khan IH.

Tuberculosis (Edinb). 2016 Dec;101:1-7. doi: 10.1016/j.tube.2016.07.008. Epub 2016 Jul 26.

PMID:
27865378
17.

Intercostal artery aneurysms: a rare presentation in Loey's-Dietz syndrome.

Subbian SK, Lim TC, Teo LL, Shankar S.

Eur J Cardiothorac Surg. 2017 Mar 1;51(3):606. doi: 10.1093/ejcts/ezw324. No abstract available.

PMID:
27694248
18.

Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis.

Unissa AN, Subbian S, Hanna LE, Selvakumar N.

Infect Genet Evol. 2016 Nov;45:474-492. doi: 10.1016/j.meegid.2016.09.004. Epub 2016 Sep 6. Review.

PMID:
27612406
19.

Pharmacologic Inhibition of Host Phosphodiesterase-4 Improves Isoniazid-Mediated Clearance of Mycobacterium tuberculosis.

Subbian S, Koo MS, Tsenova L, Khetani V, Zeldis JB, Fallows D, Kaplan G.

Front Immunol. 2016 Jun 17;7:238. doi: 10.3389/fimmu.2016.00238. eCollection 2016.

20.

Immunometabolism in Tuberculosis.

Shi L, Eugenin EA, Subbian S.

Front Immunol. 2016 Apr 21;7:150. doi: 10.3389/fimmu.2016.00150. eCollection 2016. Review.

21.

Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model.

Subbian S, Tsenova L, Holloway J, Peixoto B, O'Brien P, Dartois V, Khetani V, Zeldis JB, Kaplan G.

EBioMedicine. 2016 Jan 14;4:104-14. doi: 10.1016/j.ebiom.2016.01.015. eCollection 2016 Feb.

22.

Vaccination with an Attenuated Ferritin Mutant Protects Mice against Virulent Mycobacterium tuberculosis.

Subbian S, Pandey R, Soteropoulos P, Rodriguez GM.

J Immunol Res. 2015;2015:385402. doi: 10.1155/2015/385402. Epub 2015 Aug 3.

23.

Lesion-Specific Immune Response in Granulomas of Patients with Pulmonary Tuberculosis: A Pilot Study.

Subbian S, Tsenova L, Kim MJ, Wainwright HC, Visser A, Bandyopadhyay N, Bader JS, Karakousis PC, Murrmann GB, Bekker LG, Russell DG, Kaplan G.

PLoS One. 2015 Jul 2;10(7):e0132249. doi: 10.1371/journal.pone.0132249. eCollection 2015.

24.

Cryptococcus inositol utilization modulates the host protective immune response during brain infection.

Liu TB, Subbian S, Pan W, Eugenin E, Xie J, Xue C.

Cell Commun Signal. 2014 Sep 10;12:51. doi: 10.1186/s12964-014-0051-0.

25.

Detection of Mycobacterium tuberculosis in latently infected lungs by immunohistochemistry and confocal microscopy.

Subbian S, Eugenin E, Kaplan G.

J Med Microbiol. 2014 Nov;63(Pt 11):1432-5. doi: 10.1099/jmm.0.081091-0. Epub 2014 Aug 26.

26.

Etanercept exacerbates inflammation and pathology in a rabbit model of active pulmonary tuberculosis.

Tsenova L, O'Brien P, Holloway J, Peixoto B, Soteropoulos P, Fallows D, Kaplan G, Subbian S.

J Interferon Cytokine Res. 2014 Sep;34(9):716-26. doi: 10.1089/jir.2013.0123. Epub 2014 May 15.

27.

Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infection.

Manca C, Koo MS, Peixoto B, Fallows D, Kaplan G, Subbian S.

PLoS One. 2013 Aug 28;8(8):e74082. doi: 10.1371/journal.pone.0074082. eCollection 2013.

28.

Early innate immunity determines outcome of Mycobacterium tuberculosis pulmonary infection in rabbits.

Subbian S, Bandyopadhyay N, Tsenova L, O'Brien P, Khetani V, Kushner NL, Peixoto B, Soteropoulos P, Bader JS, Karakousis PC, Fallows D, Kaplan G.

Cell Commun Signal. 2013 Aug 19;11:60. doi: 10.1186/1478-811X-11-60.

29.

Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis.

Das R, Koo MS, Kim BH, Jacob ST, Subbian S, Yao J, Leng L, Levy R, Murchison C, Burman WJ, Moore CC, Scheld WM, David JR, Kaplan G, MacMicking JD, Bucala R.

Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):E2997-3006. doi: 10.1073/pnas.1301128110. Epub 2013 Jul 23.

30.

Molecular immunologic correlates of spontaneous latency in a rabbit model of pulmonary tuberculosis.

Subbian S, O'Brien P, Kushner NL, Yang G, Tsenova L, Peixoto B, Bandyopadhyay N, Bader JS, Karakousis PC, Fallows D, Kaplan G.

Cell Commun Signal. 2013 Feb 28;11(1):16. doi: 10.1186/1478-811X-11-16.

31.

Spontaneous latency in a rabbit model of pulmonary tuberculosis.

Subbian S, Tsenova L, O'Brien P, Yang G, Kushner NL, Parsons S, Peixoto B, Fallows D, Kaplan G.

Am J Pathol. 2012 Nov;181(5):1711-24. doi: 10.1016/j.ajpath.2012.07.019. Epub 2012 Sep 5.

32.

Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response.

Subbian S, Tsenova L, Yang G, O'Brien P, Parsons S, Peixoto B, Taylor L, Fallows D, Kaplan G.

Open Biol. 2011 Dec;1(4):110016. doi: 10.1098/rsob.110016.

33.

Strain specific transcriptional response in Mycobacterium tuberculosis infected macrophages.

Koo MS, Subbian S, Kaplan G.

Cell Commun Signal. 2012 Jan 26;10(1):2. doi: 10.1186/1478-811X-10-2.

34.

Ethics of transparency in research reports.

Selvan MS, Subbian S, Cantor SB, Rodriguez A, Smith ML, Walsh GL.

Indian J Med Ethics. 2011 Jan-Mar;8(1):31-6.

35.

Phosphodiesterase-4 inhibition alters gene expression and improves isoniazid-mediated clearance of Mycobacterium tuberculosis in rabbit lungs.

Subbian S, Tsenova L, O'Brien P, Yang G, Koo MS, Peixoto B, Fallows D, Dartois V, Muller G, Kaplan G.

PLoS Pathog. 2011 Sep;7(9):e1002262. doi: 10.1371/journal.ppat.1002262. Epub 2011 Sep 15.

36.

Phosphodiesterase-4 inhibition combined with isoniazid treatment of rabbits with pulmonary tuberculosis reduces macrophage activation and lung pathology.

Subbian S, Tsenova L, O'Brien P, Yang G, Koo MS, Peixoto B, Fallows D, Zeldis JB, Muller G, Kaplan G.

Am J Pathol. 2011 Jul;179(1):289-301. doi: 10.1016/j.ajpath.2011.03.039. Epub 2011 May 7.

37.

Phosphodiesterase 4 inhibition reduces innate immunity and improves isoniazid clearance of Mycobacterium tuberculosis in the lungs of infected mice.

Koo MS, Manca C, Yang G, O'Brien P, Sung N, Tsenova L, Subbian S, Fallows D, Muller G, Ehrt S, Kaplan G.

PLoS One. 2011 Feb 25;6(2):e17091. doi: 10.1371/journal.pone.0017091.

38.

Imaging tuberculosis with endogenous beta-lactamase reporter enzyme fluorescence in live mice.

Kong Y, Yao H, Ren H, Subbian S, Cirillo SL, Sacchettini JC, Rao J, Cirillo JD.

Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12239-44. doi: 10.1073/pnas.1000643107. Epub 2010 Jun 21.

39.

Application of optical imaging to study of extrapulmonary spread by tuberculosis.

Kong Y, Subbian S, Cirillo SL, Cirillo JD.

Tuberculosis (Edinb). 2009 Dec;89 Suppl 1:S15-7. doi: 10.1016/S1472-9792(09)70006-X.

40.

Mycobacterium tuberculosis interferes with the response to infection by inducing the host EphA2 receptor.

Khounlotham M, Subbian S, Smith R 3rd, Cirillo SL, Cirillo JD.

J Infect Dis. 2009 Jun 15;199(12):1797-806. doi: 10.1086/599096.

41.

Protection of Mycobacterium tuberculosis from reactive oxygen species conferred by the mel2 locus impacts persistence and dissemination.

Cirillo SL, Subbian S, Chen B, Weisbrod TR, Jacobs WR Jr, Cirillo JD.

Infect Immun. 2009 Jun;77(6):2557-67. doi: 10.1128/IAI.01481-08. Epub 2009 Apr 6.

42.

Use of gene dosage effects for a whole-genome screen to identify Mycobacterium marinum macrophage infection loci.

Park B, Subbian S, El-Etr SH, Cirillo SL, Cirillo JD.

Infect Immun. 2008 Jul;76(7):3100-15. doi: 10.1128/IAI.00015-08. Epub 2008 Apr 28.

43.

Construction and evaluation of luciferase reporter phages for the detection of active and non-replicating tubercle bacilli.

Dusthackeer A, Kumar V, Subbian S, Sivaramakrishnan G, Zhu G, Subramanyam B, Hassan S, Nagamaiah S, Chan J, Paranji Rama N.

J Microbiol Methods. 2008 Apr;73(1):18-25. doi: 10.1016/j.mimet.2008.01.005. Epub 2008 Jan 19.

44.
46.

A Mycobacterium marinum mel2 mutant is defective for growth in macrophages that produce reactive oxygen and reactive nitrogen species.

Subbian S, Mehta PK, Cirillo SL, Bermudez LE, Cirillo JD.

Infect Immun. 2007 Jan;75(1):127-34. Epub 2006 Oct 9.

47.

Identification of Mycobacterium marinum macrophage infection mutants.

Mehta PK, Pandey AK, Subbian S, El-Etr SH, Cirillo SL, Samrakandi MM, Cirillo JD.

Microb Pathog. 2006 Apr;40(4):139-51. Epub 2006 Jan 31.

PMID:
16451826
48.

Identification of two Mycobacterium marinum loci that affect interactions with macrophages.

El-Etr SH, Subbian S, Cirillo SL, Cirillo JD.

Infect Immun. 2004 Dec;72(12):6902-13.

Supplemental Content

Loading ...
Support Center